Dynamics of blood counts during the treatment of erythremia (polycythemia) using bioresonance and induction therapy

AUTHORS : Islamov B.I. | Gotovsky Yu.V. | Meizerov E.E.

RELEVANT UNIVERSITIES : Institute of Theoretical and Experimental Biophysics RAS, Pushchino, Federal Scientific Clinical Experimental Center for Traditional Methods of Diagnostics and Treatment of the Ministry of Health, Center “IMEDIS”, Moscow, Russia

YEAR : 2003 | Category : Method of Treatment

Polycythemia (Greek: poly – many + kytos – cage + haima – blood; synonyms: polycythemia vera, Vakez polycythemia, Vakez-Osler disease, erythremia)-tumor myeloproliferative disease of the hematopoietic system, which is characterized by a significant increase in the number of mature erythrocytes (as well as mature granulocytes and platelets simultaneously or sequentially), progressive course, absence spontaneous remissions and spontaneous healing.

Polycythemia is referred to as hemoblastosis (a group of chronic myeloid leukemia). In 1892 A. Vakez first described a syndrome characterized by dark red skin color, persistent erythrocytosis, increased hemoglobin content, and an increase in the size of the liver and spleen. In 1903 W. Osler gave a detailed description of polycythemia as a new clinical form. In 1902-1904 W. Turk expressed the idea of the hyperplastic nature of blood formation disorders in this disease and, by analogy with leukemia, called the disease erythremia [1]. The etiology is unknown. The importance of hereditary predisposition is attached.